# DESCRIPTION

## FIELD OF THE INVENTION

- define field of invention

## BACKGROUND OF THE INVENTION

- introduce membrane-derived microvesicles
- discuss RNA content and zip codes

## SUMMARY OF THE INVENTION

- introduce isolated nucleic acid molecule
- describe microvesicle composition
- outline in vitro microvesicle preparation
- summarize in vitro method of producing microvesicles

## DEFINITIONS

- define microvesicles
- define heterologous
- define isolated
- define operably linked

## DETAILED DESCRIPTION

- introduce zip code-like sequence in 3′ UTR of mRNAs
- describe function of zip code sequence in targeting mRNA to microvesicles
- outline structure of nucleic acid molecule with zip code sequence

### Nucleic Acids

- define nucleic acid molecule
- describe types of nucleic acid molecules (RNA, DNA, single-stranded, double-stranded)
- outline features of DNA molecules (regulatory sequences, coding sequences)
- describe mRNA (messenger RNA)
- describe ncRNA (non-coding RNA)
- define siRNA (short interfering RNA) and shRNA (small hairpin RNA)
- describe delivery of therapeutic nucleic acid molecules

### Zip Code Sequences

- describe specific zip code sequences
- outline functional variants of zip code sequences
- describe concatomers of zip code sequences

### Expression Vectors

- introduce expression vectors
- describe features of expression vectors (origin of replication, promoter, regulator)
- outline types of expression vectors (plasmid, virus vectors)
- describe use of expression vectors in prokaryotic and eukaryotic cells
- outline regulatory sequences in expression vectors (promoters, enhancers)
- describe termination of transcription and RNA stabilization in expression vectors

### Cells

- define cell types
- describe cell characteristics
- outline cell uses

### Exosomes/Microvesicles

- describe microvesicle production
- outline microvesicle enrichment
- define microvesicle preparation
- describe microvesicle targeting
- outline microvesicle engineering

### Delivery of Therapeutic Nucleic Acid Molecules

- describe therapeutic nucleic acid delivery

### Pharmaceutical Compositions

- define pharmaceutical composition

### Administration

- describe administration routes

### Inhibition of Microvesicle Incorporation of RNA

- describe RNA incorporation inhibition
- outline miR-1289 inhibition
- describe anti-miR-1289 use
- outline cell types for inhibition
- describe in vitro inhibition
- describe in vivo inhibition
- outline tumor cell inhibition
- describe administration methods

## EXAMPLES

### Example 1

- hypothesize zip code in 3′ UTR of mRNAs
- perform multiple sequence alignment analysis
- identify stem loop forming sequence of 25 nt
- analyze miRNA binding site for miR-1289
- perform mutational analysis of zip code sequence
- test enrichment of reporter mRNA in MVs
- evaluate translation of EGFP protein
- test requirement of CTGCC core sequence
- investigate role of miR-1289 in MV targeting
- perform miRNA database search
- test miR-1289 binding to zip code sequence
- analyze miR-1289-mediated enrichment of endogenous mRNAs
- investigate presence of miR-1289 target sites in 3′UTRs
- test degradation of mutant zip code mRNA in cells
- analyze frequency of CTGCC and miR-1289 binding sites
- predict stem loop structure of zip code sequence
- analyze secondary structures of mutant sequences
- discuss molecular mechanism of MV-mediated RNA transfer
- discuss implications for cancer and miRNA function
- motivate MV dynamics
- describe cell culture
- outline transfection and microvesicle isolation
- detail miRNA overexpression and inhibition
- explain molecular cloning and site-specific mutagenesis
- describe western blots and luciferase miRNA target reporter assay
- perform multiple sequence alignment and zip code scanning

### Example 2

- describe novel approach to selectively packaging therapeutic RNAs into extracellular vesicles

